成人自身炎症性疾病中的内源性类脂性肺炎
本文报告一例53岁免疫功能受损女性,临床表现为成人起病Still病(AOSD)且伴低外显率肿瘤坏死因子受体相关周期性综合征(TRAPS)遗传背景,因进行性呼吸困难和发热就诊,胸部CT示弥漫性肺病,支气管镜及肺泡灌洗阴性,肺活检示内源性类脂性肺炎(ELP),肺泡腔内胆固醇结晶和泡沫巨噬细胞积聚。该患者自身炎症性疾病对传统改善病情抗风湿药及托珠单抗、阿那白滞素、卡那单抗等生物制剂均难治,因未控制炎症背景下新发呼吸衰竭,排除感染后先予脉冲式全身糖皮质激素,随后环磷酰胺诱导并他克莫司维持治疗,患者康复但遗留严重间质性肺病。
要点
- 成人自身炎症性疾病患者出现弥漫性肺病且感染排查阴性时,肺活检可揭示内源性类脂性肺炎。
- 本例ELP发生于临床表现为AOSD且伴低外显率TRAPS遗传背景的免疫功能受损成人。
- 该患者自身炎症性疾病对传统改善病情抗风湿药及托珠单抗、阿那白滞素、卡那单抗均难治。
核心结论
- 本文描述一例成人自身炎症性疾病患者发生内源性类脂性肺炎,其临床表现为AOSD且伴低外显率TRAPS遗传背景,提示自身炎症性疾病肺部受累的复杂病理生理涉及固有免疫与适应性免疫的交互界面。
研究设计与样本
- 个案报告:一例53岁免疫功能受损女性,临床表现为AOSD且伴低外显率TRAPS遗传背景,有巨噬细胞活化综合征(MAS)病史。
主要发现
- 患者因进行性呼吸困难和发热就诊,胸部CT示弥漫性肺病,支气管镜及肺泡灌洗广泛检查均阴性。
- 肺活检示内源性类脂性肺炎,伴肺泡腔内胆固醇结晶积聚和泡沫巨噬细胞。
- 发病前数年,其自身炎症性疾病对传统全身改善病情抗风湿药及托珠单抗、阿那白滞素、卡那单抗等生物制剂均难治。
- 因未控制炎症背景下新发呼吸衰竭,排除感染后予脉冲式全身糖皮质激素,随后环磷酰胺诱导并他克莫司维持治疗,患者康复但遗留严重间质性肺病。
- 成人自身炎症性疾病中ELP仅有一例被描述,为诊断为AOSD的患者,而该病变在儿童全身起病型幼年特发性关节炎(soJIA)文献中更为公认。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We describe one of the first cases of endogenous lipoid pneumonia (ELP) in an adult patient with the clinical picture of adult-onset Still disease (AOSD) and a low penetrance genetic background of tumor necrosis factor receptor-associated periodic syndrome (TRAPS). This case highlights the complex pathophysiology of lung involvement in autoinflammatory diseases, operating at the interface of the innate and adaptive immune system. This case presents a 53-year-old immunocompromised woman with treatment refractory autoinflammatory disease and history of macrophage activation syndrome (MAS), presenting to the emergency room with progressive dyspnea and fever. Upon evaluation, chest computed tomography showed diffuse lung disease. Extensive workup, including bronchoscopy with bronchoalveolar lavage, remained negative. Lung biopsy revealed an ELP with intra-alveolar accumulation of cholesterol crystals and foamy macrophages. In the years preceding the event, her autoinflammatory disease had shown to be refractory to both conventional systemic disease-modifying antirheumatic drugs and biologic treatments including tocilizumab, anakinra, and canakinumab. Because of new onset respiratory failure in the context of uncontrolled inflammation, after exclusion of infectious origin, pulse doses of systemic glucocorticoids were administered before induction with cyclophosphamide, followed by maintenance therapy with tacrolimus. Upon treatment, our patient recovered but retained severe interstitial lung disease. Only one case of ELP in adult autoinflammatory disease has been depicted in a patient diagnosed with AOSD, although the entity is more recognized in pediatric literature on systemic onset juvenile idiopathic arthritis (soJIA).
引用
- Slabbynck K, Van Dorpe J, Peene I, et al. Endogenous Lipoid Pneumonia in Adult Autoinflammatory Disease. Arthritis Care Res (Hoboken). 2025. PMID: 40368851. doi:10.1002/acr.25570
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。